TY - JOUR
T1 - Impaired vascular function in asymptomatic young adult survivors of Hodgkin Lymphoma following mediastinal radiation
AU - Zelcer, Shayna
AU - Chen, Breanna
AU - Mangel, Joy
AU - Vujovic, Olga
AU - Thiessen-Philbrook, Heather R.
AU - Reider, Michael
AU - Mahmud, Farid H.
N1 - Funding Information:
Acknowledgements The following study was funded by the Law-son Health Research Institute, London, Ontario, Canada. We disclose that there is no financial relationship with the organization that sponsored the research. In addition the authors disclose that we have full control of all primary data and that we agree to allow the journal to review their data if requested.
PY - 2010
Y1 - 2010
N2 - Background: Mediastinal radiation can accelerate atherosclerosis in Hodgkin lymphoma survivors (HLS), and early detection is optimal. Peripheral arterial tonometry (PAT), a non-invasive measure of endothelial function, is a surrogate marker of sub-clinical atherosclerosis. The objective of our study was to evaluate endothelial function in HLS and controls using PAT and to determine the influence of mediastinal radiation. Procedure: Cross-sectional evaluation was performed on 26 HLS aged 12-30 years who were a minimum of 2 years from therapy, and their healthy age and gender matched controls. Evaluation included assessment for cardiovascular risk factors and completion of the Habitual Activity Estimation Score (HAES) questionnaire to assess activity level. Endothelial Function was measured using PAT hyperemia ratios (PAT-HR). Results: HLS and controls were similar for baseline variables (mean age 23. 3 ± 5 yrs vs. 23. 4 ± 4. 8 yrs, p = 0. 92). HLS were on average 6. 7 ± 4. 6 yrs post treatment. No differences in endothelial function or cardiovascular risk factors were observed between HLS and controls. However, impaired endothelial function, as evidenced by lower PAT-HR (1. 67 ± 0. 39 vs. 2. 03 ± 0. 37, p < 0. 01) was seen in HLS (n = 13) who received mediastinal radiation (mean radiation dose 2,600 ± 840 cGy) compared to controls. Conclusions: Impaired endothelial function was preferentially observed in HLS who received mediastinal radiation, while no difference was observed between the HLS and control groups overall. This finding, assessed using a non invasive test of endothelial function, confirms that mediastinal radiation is an additional cardiovascular risk factor in this young cohort of patients. Further studies of endothelial function in this patient population are warranted.
AB - Background: Mediastinal radiation can accelerate atherosclerosis in Hodgkin lymphoma survivors (HLS), and early detection is optimal. Peripheral arterial tonometry (PAT), a non-invasive measure of endothelial function, is a surrogate marker of sub-clinical atherosclerosis. The objective of our study was to evaluate endothelial function in HLS and controls using PAT and to determine the influence of mediastinal radiation. Procedure: Cross-sectional evaluation was performed on 26 HLS aged 12-30 years who were a minimum of 2 years from therapy, and their healthy age and gender matched controls. Evaluation included assessment for cardiovascular risk factors and completion of the Habitual Activity Estimation Score (HAES) questionnaire to assess activity level. Endothelial Function was measured using PAT hyperemia ratios (PAT-HR). Results: HLS and controls were similar for baseline variables (mean age 23. 3 ± 5 yrs vs. 23. 4 ± 4. 8 yrs, p = 0. 92). HLS were on average 6. 7 ± 4. 6 yrs post treatment. No differences in endothelial function or cardiovascular risk factors were observed between HLS and controls. However, impaired endothelial function, as evidenced by lower PAT-HR (1. 67 ± 0. 39 vs. 2. 03 ± 0. 37, p < 0. 01) was seen in HLS (n = 13) who received mediastinal radiation (mean radiation dose 2,600 ± 840 cGy) compared to controls. Conclusions: Impaired endothelial function was preferentially observed in HLS who received mediastinal radiation, while no difference was observed between the HLS and control groups overall. This finding, assessed using a non invasive test of endothelial function, confirms that mediastinal radiation is an additional cardiovascular risk factor in this young cohort of patients. Further studies of endothelial function in this patient population are warranted.
KW - Cardiotoxicity after cancer therapy
KW - Late effects
KW - Lymphoma
UR - http://www.scopus.com/inward/record.url?scp=78649629978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649629978&partnerID=8YFLogxK
U2 - 10.1007/s11764-010-0138-6
DO - 10.1007/s11764-010-0138-6
M3 - Article
C2 - 20652436
AN - SCOPUS:78649629978
SN - 1932-2259
VL - 4
SP - 218
EP - 224
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
IS - 3
ER -